In this episode of This Is Purdue, we’re featuring a Boilermaker whose innovations are changing and saving lives across the world.   Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.   Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)

Purdue Celebrates Black History Month

This Is Purdue, the official podcast for Purdue University, highlights stories about Boilermakers from across all disciplines, who through research, innovation and determination, have persistently pursued their next giant leap.

Hosted by Purdue University alum, Brian Lamb School of Communication graduate, and Indiana native Kate Young, This is Purdue aims to examine all of the incredible accomplishments of Boilermakers and their contributions to the world.

Join us every other Thursday as we interview students, faculty, and alumni taking small steps toward their giant leaps, and inspiring others to do the same.